Supplemental Figure 1 : Treatment of human NSCLC bearing xenografts with pemetrexed and cisplatin resulted in significant tumor growth inhibition. (a.) H460 bearing mouse xenografts were either treated as controls or given combination therapy with pemetrexed and cisplatin and tumors were measured over a 2 week course of therapy. (b., c.) Tumors were excised at necropsy demonstrating a significantly larger tumors in the (b.) control group relative to those (c.) treated with cisplatin and pemetrexed.
